Explore 3 Stock Ideas & Industry Insights Download Free Report

BioForce Nanosciences Holdings Inc

Company price
6.7 USD 0.44 ( 7.03%)
Last update at 2026-11-06T20:58:00Z
VOLUME
2000
Market Cap
318.72M

Momentum Score

…

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
6.70
Low
6.90
High
52 Week Price Range
0.18
Low
10.99
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
6.26
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-0.12
ROE
-10.15%
Net Debt
-0.00M
ROCE
79.21%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.49M -0.49M -0.47M -0.49M -0.50M
Net income -1.29M -0.49M -0.47M -0.49M -0.50M
Selling general administrative 0.07M 0.07M 0.47M 0.49M 0.50M
Selling and marketing expenses - - - - 0.42M
Gross profit 0.00M 0.00M 0.00M 0.00M 0.00M
Ebit - - -0.94M -0.49M -0.50M
Ebitda -0.49M -0.49M -0.47M -0.49M -0.50M
Depreciation and amortization - - 0.47M - -
Operating income -0.49M -0.49M -0.47M -0.49M -0.50M
Other operating expenses 0.49M 0.49M 0.47M 0.49M 0.50M
Interest expense - - - - 0.00M
Income tax expense - - -0.47M - -
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 0.49M 0.49M 0.47M 0.49M 0.50M
Cost of revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total other income expense net -0.80M - -0.00M - -
Net income from continuing ops -1.29M -0.49M -0.47M -0.49M -0.50M
Net income applicable to common shares - - - -0.49M -0.50M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.00M 0.00M 0.00M 0.00M 0.01M
Other current assets - - - - 0.00M
Total liab 0.62M 2.30M 1.82M 1.35M 0.87M
Total stockholder equity -0.62M -2.30M -1.82M -1.35M -0.86M
Other current liab 0.62M 2.02M 1.82M 1.35M 0.87M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings -162.41M -161.12M -160.63M -160.16M -159.67M
Cash 0.00M 0.00M 0.00M 0.00M 0.01M
Total current liabilities 0.62M 2.30M 1.82M 1.35M 0.87M
Current deferred revenue - - -0.22M - -
Net debt -0.00M -0.00M -0.00M -0.00M -0.01M
Short term debt - 0.27M 0.22M - -
Short long term debt total - - 0.22M - -
Other stockholder equity 161.76M 158.79M 158.78M 158.78M 158.78M
Total current assets 0.00M 0.00M 0.00M 0.00M 0.01M
Net tangible assets - - - -1.35M -0.86M
Accounts payable 0.01M 0.01M 0.00M 0.00M 0.01M
Common stock total equity - - - - 0.03M
Retained earnings total equity - - - - -159.67M
Non current assets total 0.00M 0.00M 0.00M 0.00M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M 0.00M 0.00M 0.00M
Change to liabilities - - - -0.01M 0.00M
Net borrowings - - - 0.06M 0.05M
Total cash from financing activities 0.07M 0.06M 0.05M 0.06M 0.05M
Change to operating activities - - - 0.42M 0.42M
Net income -1.29M -0.49M -0.47M -0.49M -0.50M
Change in cash -0.00M 0.00M -0.00M -0.01M -0.03M
Begin period cash flow 0.00M 0.00M 0.00M 0.01M 0.04M
End period cash flow 0.00M 0.00M 0.00M 0.00M 0.01M
Total cash from operating activities -0.07M -0.06M -0.05M -0.07M -0.08M
Issuance of capital stock 0.00M 0.01M 0.00M 0.00M -
Other cashflows from financing activities 0.07M 0.05M 0.05M 0.06M 0.05M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Cash flows other operating - - - - -0.00M
Cash and cash equivalents changes - - - - -0.03M
Change in working capital 0.42M 0.43M 0.43M 0.42M 0.42M
Stock based compensation 0.42M 0.42M - 0.42M 0.42M
Other non cash items 0.81M 0.43M -0.00M -0.42M -0.42M
Free cash flow -0.07M -0.06M -0.05M -0.07M -0.08M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BFNH
BioForce Nanosciences Holdings Inc
0.44
7.03%
6.70 - - 3840.95 141.43 3843.22 -102.89
NSRGF
Nestle SA
-1.51
1.43%
104.11 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
-2.25
2.11%
104.18 26.82 18.66 3.18 7.07 3.81 21.70
DANOY
Danone PK
-0.43
2.79%
14.96 24.23 17.64 1.88 2.57 1.88 11.70
GPDNF
Danone S.A
-
-%
75.84 20.30 14.75 1.65 2.24 1.76 10.92

Profile*

BioForce Nanosciences Holdings Inc

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

2020 General Booth Blvd., Virginia Beach, VA, United States, 23454

757 306 6090

3

Name Title Year Born
Mr. Steven Gagnon Co-Chief Exec. Officer 1962
Mr. John LaViolette Co-Chief Exec. Officer 1961
Mr. Aleksandr Shapiro Pres 1960
Mr. Richard Kaiser CFO, Corp. Sec., Corp. Governance Officer, Principal Accounting Officer & Director 1966
Mr. Richard Kaiser CFO, Corporate Secretary, Corporate Governance Officer, Principal Accounting Officer & Director 1966
Mr. Steven Gagnon Co-Chief Executive Officer 1962
Mr. John LaViolette Co-Chief Executive Officer 1962
Mr. Aleksandr Shapiro President 1963
Mr. Richard Kaiser Interim CEO, CFO, Corp Secretary, Corp Governance Officer, Principal Acc Officer & Director 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…